Home/Filings/4/0000950170-24-099872
4//SEC Filing

Halperin Wernli Miri 4

Accession 0000950170-24-099872

CIK 0001813814other

Filed

Aug 21, 8:00 PM ET

Accepted

Aug 22, 4:30 PM ET

Size

9.1 KB

Accession

0000950170-24-099872

Insider Transaction Report

Form 4
Period: 2024-08-21
Wernli Miri Halperin
DirectorExecutive President
Transactions
  • Exercise/Conversion

    Common Shares

    2024-08-21$3.70/sh+50,000$185,000235,000 total
  • Tax Payment

    Common Shares

    2024-08-21$6.17/sh32,595$201,111202,405 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-08-2150,0000 total
    Exercise: $3.70Exp: 2025-02-27Common Shares (50,000 underlying)
Footnotes (3)
  • [F1]Exercise of Reporting Person's stock option that would otherwise expire February 27, 2025.
  • [F2]Transaction represents a "net exercise" of an outstanding stock option to purchase an aggregate of 50,000 common shares of the Issuer granted on February 27, 2020. The Reporting Person received 17,405 common shares of the Issuer on the net exercise of the stock option. The Issuer withheld 32,595 common shares underlying the stock option for payment of the exercise price and tax withholding using a stock price of $6.17, which represents the closing price of the Issuer's common shares on August 20, 2024, the day before the exercise.
  • [F3]Represents the option to purchase 50,000 common shares of the Issuer, which vested over a period of four years following the date of the grant of February 27, 2020. All such options are fully vested.

Documents

1 file

Issuer

Mind Medicine (MindMed) Inc.

CIK 0001813814

Entity typeother

Related Parties

1
  • filerCIK 0001897615

Filing Metadata

Form type
4
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 4:30 PM ET
Size
9.1 KB